Gilead Sciences, Inc. (GILD) Tops Q3 EPS by 4c; Raises FY13 Sales Outlook

October 29, 2013 4:03 PM

Gilead Sciences, Inc. (NASDAQ: GILD) reported Q3 EPS of $0.52, $0.04 better than the analyst ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found